|
Apr 30
|
Why Chimerix Inc. (CMRX) is Surging in 2025
|
|
Apr 1
|
Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?
|
|
Mar 31
|
Exploring US High Growth Tech Stocks In March 2025
|
|
Mar 26
|
Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025
|
|
Mar 21
|
Chimerix: Q4 Earnings Snapshot
|
|
Mar 21
|
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
|
|
Feb 21
|
Exploring Three High Growth Tech Stocks in the United States
|
|
Feb 18
|
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Feb 18
|
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
|
|
Feb 17
|
Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor
|
|
Dec 30
|
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
|